Supplements and talk therapy may ease Alcohol's toll on the liver
NCT ID NCT07603726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested whether a combination of nutraceutical supplements and psychological support could lower GGT, a liver enzyme, in 197 adults with alcohol use disorder. Participants received liver-supporting supplements and counseling to reduce drinking. The goal was to see if this dual approach could reduce alcohol-related liver stress.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nutraceutical supplements (hepatoprotective compounds)
- What this could lead to
- If successful, this combined approach could offer a practical way to reduce alcohol-related liver stress and support recovery in people with alcohol use disorder.
- What could go wrong
- This is a completed early-stage study with no phase designation, so results may not be definitive. The intervention is not a cure and relies on participants' adherence to both supplements and counseling.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
197 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of Alcohol Use Disorder * Elevated baseline gamma-glutamyl transferase (GGT) levels * Ability to provide informed consent Exclusion Criteria: * Severe liver disease (e.g., cirrhosis or hepatic failure) * Severe psychiatric disorders interfering with participation * Current participation in another clinical study * Incomplete clinical or laboratory data
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol use disorder (AUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical Center TOPMED
Târgu Mureş, Mureș County, 540058, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can just seeing and smelling a drink trigger alcohol cravings?
- Can a diabetes drug curb alcohol cravings?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Zapping the brain to fight alcoholism: a new hope?
- Rewiring the brain to fight alcohol cravings?
- Can cash rewards and a breathalyzer app help people stay sober?